Defining Nonadherence and Nonpersistence to Anti-Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular Degeneration

Creative Commons License

Okada M., Wong T. Y., Mitchell P., Eldem B., Talks S. J., Aslam T., ...Daha Fazla

JAMA OPHTHALMOLOGY, cilt.139, ss.769-776, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 139
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1001/jamaophthalmol.2021.1660
  • Dergi Adı: JAMA OPHTHALMOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.769-776
  • Hacettepe Üniversitesi Adresli: Evet

Özet

IMPORTANCE Poor adherence or persistence to treatment can be a barrier to optimizing clinical practice (real-world) outcomes to intravitreal injection therapy in patients with neovascular age-related macular degeneration (nAMD). Currently, there is a lack of consensus on the definition and classification of adherence specific to this context.